Your browser doesn't support javascript.
loading
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023.
Link-Gelles, Ruth; Weber, Zachary A; Reese, Sarah E; Payne, Amanda B; Gaglani, Manjusha; Adams, Katherine; Kharbanda, Anupam B; Natarajan, Karthik; DeSilva, Malini B; Dascomb, Kristin; Irving, Stephanie A; Klein, Nicola P; Grannis, Shaun J; Ong, Toan C; Embi, Peter J; Dunne, Margaret M; Dickerson, Monica; McEvoy, Charlene; Arndorfer, Julie; Naleway, Allison L; Goddard, Kristin; Dixon, Brian E; Griggs, Eric P; Hansen, John; Valvi, Nimish; Najdowski, Morgan; Timbol, Julius; Rogerson, Colin; Fireman, Bruce; Fadel, William F; Patel, Palak; Ray, Caitlin S; Wiegand, Ryan; Ball, Sarah; Tenforde, Mark W.
Afiliación
  • Link-Gelles R; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC. Electronic address: media@cdc.gov.
  • Weber ZA; Westat, Rockville, Maryland.
  • Reese SE; Westat, Rockville, Maryland.
  • Payne AB; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Gaglani M; Section of Pediatric Infectious Diseases, Department of Pediatrics, Baylor Scott & White Health, Temple, Texas; Department of Medical Education, Texas A&M University College of Medicine, Temple, Texas.
  • Adams K; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Kharbanda AB; Children's Minnesota, Minneapolis, Minnesota.
  • Natarajan K; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York; NewYork-Presbyterian Hospital, New York, New York.
  • DeSilva MB; HealthPartners Institute, Minneapolis, Minnesota.
  • Dascomb K; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah.
  • Irving SA; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California.
  • Grannis SJ; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana; School of Medicine, Indiana University, Indianapolis, Indiana.
  • Ong TC; School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Embi PJ; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Dunne MM; Westat, Rockville, Maryland.
  • Dickerson M; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
  • McEvoy C; HealthPartners Institute, Minneapolis, Minnesota.
  • Arndorfer J; Division of Infectious Diseases and Clinical Epidemiology, Intermountain Healthcare, Salt Lake City, Utah.
  • Naleway AL; Kaiser Permanente Center for Health Research, Portland, Oregon.
  • Goddard K; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California.
  • Dixon BE; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana.
  • Griggs EP; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Hansen J; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California.
  • Valvi N; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana.
  • Najdowski M; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Timbol J; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California.
  • Rogerson C; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana.
  • Fireman B; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California Division of Research, Oakland, California.
  • Fadel WF; Center for Biomedical Informatics, Regenstrief Institute, Indianapolis, Indiana; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana.
  • Patel P; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Ray CS; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Wiegand R; Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC.
  • Ball S; Westat, Rockville, Maryland.
  • Tenforde MW; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC.
Am J Transplant ; 23(7): 1062-1076, 2023 07.
Article en En | MEDLINE | ID: mdl-37394267

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Crítica / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad Crítica / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article